Rationale and Budget Impact of Bimonthly Use of Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Head and Neck - United States
doi 10.1002/hed.25481
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley